Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Cited by CrossRef (15)

  1. Fengli Sun, Fang Yu, Zhihan Gao, Zhibin Ren, Weidong Jin. Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride. Asian Journal of Psychiatry 2021;62:102694
  2. Jung-Jin Kim, Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand. Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia. Clin Psychopharmacol Neurosci 2021;19:600
  3. Ivan V. Maly, Michael J. Morales, Mikhail V. Pletnikov. Astrocytes in Psychiatric Disorders. 2021.
  4. Jean Claude Martel, Silvia Gatti McArthur. Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. Front. Pharmacol. 2020;11
  5. Stefano Barlati, Cassandra Ariu, Andrea Garozzo, Antonio Vita. Psychosis and Personality Disorders. 2020.
  6. Chi-Un Pae. Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?. Chonnam Med J 2020;56:157
  7. Bin Zhou, Weiping Kuang, Hongxing Huang, Yong Zhu, Xiaofeng Chen, Liang Li, Ping Yang. Successful Treatment of Psychiatric Symptoms after Traumatic Brain Injury Using Deep Brain Stimulation to the Anterior Limb of Internal Capsule-Nucleus Accumbens. Clin Psychopharmacol Neurosci 2020;18:636
  8. Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand. Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?. Clin Psychopharmacol Neurosci 2021;19:434
  9. Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand. Effectiveness and Tolerability of Switching to Aripiprazole Once Monthly from Antipsychotic Polypharmacy and/or Other Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study. Clin Psychopharmacol Neurosci 2020;18:153
  10. Ming-Huan Zhu, Zhen-Jing Liu, Qiong-Yue Hu, Jia-Yu Yang, Ying Jin, Na Zhu, Ying Huang, Dian-Hong Shi, Min-Jia Liu, Hong-Yang Tan, Lei Zhao, Qin-Yu Lv, Zheng-Hui Yi, Feng-Chun Wu, Ze-Zhi Li. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial. Military Med Res 2022;9
  11. Alma Hrnjadovic, James Friedmann, Sandra Barhebreus, Patricia J. Allen, Bernat Kocsis. Effect of a 5-HT7 Receptor Antagonist on Reversal Learning in the Rat Attentional Set-Shifting Test. ACS Chem. Neurosci. 2021;12:42
  12. Ji Sun Kim, Young Joon Kwon, Hwa Young Lee, Ho-Sung Lee, Sungkean Kim, Se-hoon Shim. Mismatch Negativity Indices as a Prognostic Factor for Remission in Schizophrenia. Clin Psychopharmacol Neurosci 2020;18:127
  13. Ahmed M. Mohamed, Mohamed Z. Habib, Mai A. Ebeid, Sahar M. Abdelraouf, Yasser el Faramawy, Sawsan Aboul-Fotouh, Yosra Magdy. Amisulpride alleviates chronic mild stress-induced cognitive deficits: Role of prefrontal cortex microglia and Wnt/β-catenin pathway. European Journal of Pharmacology 2020;885:173411
  14. Xiuli Wang, Bochao Cheng, Neil Roberts, Song Wang, Ya Luo, Fangfang Tian, Suping Yue. Shared and distinct brain fMRI response during performance of working memory tasks in adult patients with schizophrenia and major depressive disorder. Human Brain Mapping 2021;42:5458
  15. Radwa S. Raafat, Mohamed Z. Habib, Amany A. AbdElfattah, Nouran K. Olama, Sahar M. Abdelraouf, Nevien Hendawy, Khaled A. Kamal, Salwa A. Nawishy, Sawsan Aboul-Fotouh:. Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats. International Immunopharmacology 2023;124:110945